Pfizer Investigational Site is a clinical research site located in Cleveland, Ohio, United States 44106-5080.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Pfizer Investigational Site has participated in 112 clinical trials.
Therapeutic areas: Bipolar Disorder, Carcinoma, Renal Cell, Pulmonary Arterial Hypertension.
Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Pfizer, Wyeth is now a wholly owned subsidiary of Pfizer.
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Pfizer Investigational Site has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Pfizer Investigational Site has 112 clinical trials on record. Their work covers Bipolar Disorder, Carcinoma, Renal Cell, Pulmonary Arterial Hypertension.
Pfizer Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.